Moreover, in another study, it was found that the inhibition of fatty acid transport protein 2 (FATP2) resulted in the suppression of MYCN-induced glycerolipid accumulation and tumor growth in preclinical NB models [57]. This evidence concerns the gene SLC27A2 and neoplasm.